321 results on '"Schmidt, Aline"'
Search Results
2. NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients
3. Toxicity Profile According to Etoposide and Cytarabine Dosing in Patients with Lymphoma Receiving Autologous Stem Cell Transplantation Following BEAM Conditioning
4. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
5. Serum phosphate level and its kinetic as an early marker of acute kidney injury in tumor lysis syndrome
6. Antifungal Prophylaxis in AML Patients Receiving Intensive Induction Chemotherapy: A Prospective Observational Study From the Acute Leukaemia French Association (ALFA) Group
7. Pneumocystis Pneumonia After Allogeneic Hematopoietic Cell Transplantation: A Case-Control Study on Epidemiology and Risk Factors on Behalf of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
8. La transition vers l’âge adulte: une période charnière dans la prise en charge continue des jeunes patients
9. JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes
10. Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL
11. Slower degradation rate of cytarabine in blood samples from acute myeloid leukemia by comparison with control samples
12. Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantation
13. Seconde allogreffe : recommandations de la Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
14. Chapter 18 - Beyond the beverages: turning winery and brewery wastes into value-added products
15. Pneumocystis pneumonia after allogeneic hematopoietic cell transplantation: A case-control study on epidemiology and risk factors on behalf of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
16. ASSOCIAÇÃO DE DOENÇAS SISTÊMICAS NA PREVALÊNCIA DE INFECÇÕES ENDODÔNTICAS E NO SUCESSO DO TRATAMENTO ENDODÔNTICO
17. USO DE ÓLEOS ESSENCIAIS NA DESINFECÇÃO DO SISTEMA DE CANAIS RADICULARES: UMA REVISÃO DE LITERATURA
18. Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond–like syndrome
19. Impact of front line relative dose intensity for methotrexate and comorbidities in immunocompetent elderly patients with primary central nervous system lymphoma
20. Decomposition of Phenotypic Variation of White Oats by Meteorological and Geographic Covariables
21. Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up
22. Early Post-Transplantation Serum Ferritin Level Predicts Survival in Recipients of Haploidentical Stem Cell Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis
23. Comparison of efficacy and toxicity according to etoposide and cytarabine dosing in BEAM conditioning followed by autologous stem cell transplantation in Hodgkin lymphoma.
24. Allogeneic stem cell transplantation recipients requiring intensive care: time is of the essence
25. Applications of Brewer’s Spent Grain Hemicelluloses in Biorefineries: Extraction and Value-Added Product Obtention
26. Implementation of a new blood cultures sampling strategy in patients receiving intensive chemotherapy for acute leukemia and/or hematopoietic cell transplantation
27. Relationship between comorbidities, mutational profile, and outcome after intensive chemotherapy in patients older than 60 years with acute myeloid leukemia: Assessment of different risk scores
28. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
29. The p16INK4A/pRb pathway and telomerase activity define a subgroup of Ph+ adult Acute Lymphoblastic Leukemia associated with inferior outcome
30. Prevalence of Osteoporosis in Myelodysplastic Syndrome Patients and Association with Cytopenias
31. Long-Term Survival of Acute Myeloid Leukemia Responding Patients Who Stopped Azacytidine and/or Venetoclax Because of Poor Tolerance or Physician Choice: A Retrospective Multicenter Study from the French Innovative Leukemia Organization (FILO)
32. Dose of IV Busulfan in Reduced Toxicity Conditioning Regimen for Older and/or Frail Patients with AML or MDS
33. List of contributors
34. Study of oxidative and inflammatory parameters in LDLr-KO mice treated with a hypercholesterolemic diet: comparison between the use of Campomanesia xanthocarpa and acetylsalicylic acid
35. ECONOMIC AND AGRONOMIC POSITIONING OF FUNGICIDES IN CONDITIONS OF WATER DEFICIT IN SOYBEAN CULTURES
36. Long-Term Follow-Up of the Imatinib GRAAPH-2003 Study in Newly Diagnosed Patients with De Novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A GRAALL Study
37. Different Impact of the Number of Organ Failures and Graft-Versus-Host Disease on the Outcome of Allogeneic Stem Cell Transplantation Recipients Requiring Intensive Care
38. Daunorubicin and Its Active Metabolite Pharmacokinetic Profiles in Acute Myeloid Leukaemia Patients: A Pharmacokinetic Ancillary Study of the BIG-1 Trial
39. Treatment by Lenalidomide in lower risk myelodysplastic syndrome with 5q deletion—The GFM experience
40. LICITAÇÕES VIRTUAIS: UM ESTUDO DE PROSPECÇÃO TECNOLÓGICA ACERCA DA PRESTAÇÃO DE SERVIÇOS PELA INICIATIVA PRIVADA
41. Assisted suicide under Swiss law
42. Impact of allogeneic stem cell transplantation comorbidity indexes after haplotransplant using post‐transplant cyclophosphamide
43. Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience
44. Risk of infection according to the gamma globulin level in the 100 days following allogeneic stem cell transplantations
45. Additional file 1 of Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL
46. Additional file 2 of Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL
47. Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL.
48. Association between Molecular Profile and Outcome after Intensive Chemotherapy in Patients > 60 Years with Adverse Cytogenetic Risk and/or Secondary Acute Myeloid Leukemia - a Filo Study
49. NGS-Based Stratification Refines the Risk Stratification in T-ALL and Identifies a Very High-Risk Subgroup of Patients
50. Long-term follow-up and second malignancies in 487 patients with hairy cell leukaemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.